vs
ISABELLA BANK CORP（ISBA）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是ISABELLA BANK CORP的1.7倍（$35.5M vs $21.2M），ISABELLA BANK CORP净利率更高（22.2% vs -304.2%，领先326.4%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 14.3%），ISABELLA BANK CORP自由现金流更多（$23.3M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 12.6%）
菲律宾群岛银行是菲律宾的全能型银行，同时也是菲律宾乃至整个东南亚历史最悠久的银行。按资产规模计算，它是菲律宾第四大银行；按市值计算则位列第二，是菲律宾盈利能力最强的银行之一。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ISBA vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.7倍
$21.2M
营收增速更快
RXRX
高出667.5%
14.3%
净利率更高
ISBA
高出326.4%
-304.2%
自由现金流更多
ISBA
多$70.7M
$-47.3M
两年增速更快
RXRX
近两年复合增速
12.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.2M | $35.5M |
| 净利润 | $4.7M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 32.2% | -304.8% |
| 净利率 | 22.2% | -304.2% |
| 营收同比 | 14.3% | 681.7% |
| 净利润同比 | 17.4% | 39.6% |
| 每股收益（稀释后） | $0.64 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ISBARXRX
| Q4 25 | $21.2M | $35.5M | ||
| Q3 25 | $20.5M | $5.2M | ||
| Q2 25 | $18.8M | $19.2M | ||
| Q1 25 | $18.1M | $14.7M | ||
| Q4 24 | $18.5M | $4.5M | ||
| Q3 24 | $18.0M | $26.1M | ||
| Q2 24 | $17.2M | $14.4M | ||
| Q1 24 | $16.7M | $13.8M |
净利润ISBARXRX
| Q4 25 | $4.7M | $-108.1M | ||
| Q3 25 | $5.2M | $-162.3M | ||
| Q2 25 | $5.0M | $-171.9M | ||
| Q1 25 | $3.9M | $-202.5M | ||
| Q4 24 | $4.0M | $-178.9M | ||
| Q3 24 | $3.3M | $-95.8M | ||
| Q2 24 | $3.5M | $-97.5M | ||
| Q1 24 | $3.1M | $-91.4M |
毛利率ISBARXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率ISBARXRX
| Q4 25 | 32.2% | -304.8% | ||
| Q3 25 | 30.7% | -3327.6% | ||
| Q2 25 | 32.8% | -916.8% | ||
| Q1 25 | 26.9% | -1297.9% | ||
| Q4 24 | 26.0% | -4042.4% | ||
| Q3 24 | 21.3% | -377.1% | ||
| Q2 24 | 23.9% | -697.4% | ||
| Q1 24 | 21.8% | -698.4% |
净利率ISBARXRX
| Q4 25 | 22.2% | -304.2% | ||
| Q3 25 | 25.6% | -3135.3% | ||
| Q2 25 | 26.7% | -894.2% | ||
| Q1 25 | 21.9% | -1373.3% | ||
| Q4 24 | 21.6% | -3935.5% | ||
| Q3 24 | 18.2% | -367.5% | ||
| Q2 24 | 20.3% | -676.6% | ||
| Q1 24 | 18.7% | -662.4% |
每股收益（稀释后）ISBARXRX
| Q4 25 | $0.64 | $-0.17 | ||
| Q3 25 | $0.71 | $-0.36 | ||
| Q2 25 | $0.68 | $-0.41 | ||
| Q1 25 | $0.53 | $-0.50 | ||
| Q4 24 | $0.54 | $-0.56 | ||
| Q3 24 | $0.44 | $-0.34 | ||
| Q2 24 | $0.46 | $-0.40 | ||
| Q1 24 | $0.42 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $26.0M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $231.4M | $1.1B |
| 总资产 | $2.2B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ISBARXRX
| Q4 25 | $26.0M | $743.3M | ||
| Q3 25 | $161.3M | $659.8M | ||
| Q2 25 | $108.6M | $525.1M | ||
| Q1 25 | $69.2M | $500.5M | ||
| Q4 24 | $24.5M | $594.4M | ||
| Q3 24 | $27.4M | $427.6M | ||
| Q2 24 | $23.6M | $474.3M | ||
| Q1 24 | $25.2M | $296.3M |
总债务ISBARXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益ISBARXRX
| Q4 25 | $231.4M | $1.1B | ||
| Q3 25 | $227.4M | $1.0B | ||
| Q2 25 | $220.5M | $919.1M | ||
| Q1 25 | $215.6M | $933.9M | ||
| Q4 24 | $210.3M | $1.0B | ||
| Q3 24 | $213.0M | $524.6M | ||
| Q2 24 | $202.2M | $584.4M | ||
| Q1 24 | $200.7M | $401.2M |
总资产ISBARXRX
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.3B | $1.4B | ||
| Q2 25 | $2.2B | $1.3B | ||
| Q1 25 | $2.1B | $1.3B | ||
| Q4 24 | $2.1B | $1.4B | ||
| Q3 24 | $2.1B | $726.5M | ||
| Q2 24 | $2.1B | $775.9M | ||
| Q1 24 | $2.1B | $557.8M |
负债/权益比ISBARXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $23.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | 110.2% | -133.1% |
| 资本支出强度资本支出/营收 | 16.4% | 3.5% |
| 现金转化率经营现金流/净利润 | 5.72× | — |
| 过去12个月自由现金流最近4个季度 | $36.0M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流ISBARXRX
| Q4 25 | $26.8M | $-46.1M | ||
| Q3 25 | $2.7M | $-117.4M | ||
| Q2 25 | $7.8M | $-76.4M | ||
| Q1 25 | $4.7M | $-132.0M | ||
| Q4 24 | $19.6M | $-115.4M | ||
| Q3 24 | $3.6M | $-59.2M | ||
| Q2 24 | $5.5M | $-82.2M | ||
| Q1 24 | $3.4M | $-102.3M |
自由现金流ISBARXRX
| Q4 25 | $23.3M | $-47.3M | ||
| Q3 25 | $1.7M | $-117.6M | ||
| Q2 25 | $7.2M | $-79.6M | ||
| Q1 25 | $3.7M | $-133.8M | ||
| Q4 24 | $17.5M | $-116.7M | ||
| Q3 24 | $3.2M | $-63.8M | ||
| Q2 24 | $5.1M | $-83.4M | ||
| Q1 24 | $2.6M | $-109.0M |
自由现金流率ISBARXRX
| Q4 25 | 110.2% | -133.1% | ||
| Q3 25 | 8.5% | -2272.5% | ||
| Q2 25 | 38.5% | -413.9% | ||
| Q1 25 | 20.6% | -907.4% | ||
| Q4 24 | 94.6% | -2567.7% | ||
| Q3 24 | 17.7% | -244.6% | ||
| Q2 24 | 29.8% | -578.5% | ||
| Q1 24 | 15.7% | -789.9% |
资本支出强度ISBARXRX
| Q4 25 | 16.4% | 3.5% | ||
| Q3 25 | 5.0% | 4.7% | ||
| Q2 25 | 3.2% | 16.4% | ||
| Q1 25 | 5.5% | 12.4% | ||
| Q4 24 | 11.4% | 28.6% | ||
| Q3 24 | 2.0% | 17.5% | ||
| Q2 24 | 2.4% | 8.2% | ||
| Q1 24 | 4.9% | 48.2% |
现金转化率ISBARXRX
| Q4 25 | 5.72× | — | ||
| Q3 25 | 0.52× | — | ||
| Q2 25 | 1.56× | — | ||
| Q1 25 | 1.19× | — | ||
| Q4 24 | 4.91× | — | ||
| Q3 24 | 1.08× | — | ||
| Q2 24 | 1.59× | — | ||
| Q1 24 | 1.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
